6/1/2022 7:01:17 AM
VTv Therapeutics Invests By And Entry Into Collaboration And License Agreement With Affiliates Of G42 Healthcare
3/3/2022 8:54:02 PM
VTv Therapeutics Appoints Rich Nelson As Acting CEO
11/9/2021 8:34:24 AM
VTv Therapeutics Q2 Loss Per Share $0.02 Vs Loss $0.01 Last Year
10/20/2021 9:03:14 AM
VTv Therapeutics Appoints Deepa Prasad As President And CEO
10/12/2021 7:59:49 AM
VTv Therapeutics Says Mechanistic Study Of TTP399 In Patients With Type 1 Diabetes Primary Endpoint
9/24/2021 7:15:49 AM
VTv Therapeutics Announces Results Of MAD Study Of HPP737 In Healthy Adults